Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Bremer

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
ISRN Oncology|July 11, 2013
Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapyEdwin Bremer
Molecular Cancer Therapeutics|October 7, 2010
A better TRAIL variant for tumor cell-specific targeting? - letterEdwin Bremer, Wijnand Helfrich
Discovery Medicine|January 20, 2007
Targeting the messengers of death: the advent of selective activation of apoptosis for cancer therapyEdwin Bremer, Wijnand Helfrich
Methods in Molecular Biology (Clifton, N.J.)|February 6, 2014
Bifunctional antibody fragment-based fusion proteins for the targeted elimination of pathogenic T-cell subsetsWijnand Helfrich, Edwin Bremer
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Direct and indirect rituximab-induced T cell depletion: comment on the article by Mélet et AlPaul Eggleton, Edwin Bremer
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
EpCAM-targeted induction of apoptosisEdwin Bremer, Wijnand Helfrich
Methods in Molecular Biology (Clifton, N.J.)|May 22, 2025
A Luminescence-Based Method for In Vitro Screening of Immunomodulatory Checkpoints and TherapeuticsJimena Álvarez Freile, Edwin Bremer
Frontiers in Oncology|December 5, 2015
Editorial: Endoplasmic Reticulum and Its Role in Tumor ImmunityPaul Eggleton, Marek Michalak, Edwin Bremer
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
Development of Bispecific Antibody Derivatives for Cancer ImmunotherapyYuan He, Wijnand Helfrich, Edwin Bremer
Frontiers in Cell and Developmental Biology|June 17, 2022
Towards Immunotherapy-Induced Normalization of the Tumor MicroenvironmentVinicio Melo, Edwin Bremer, John D Martin
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
ISRN Oncology|July 11, 2013
Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapyEdwin Bremer
Molecular Cancer Therapeutics|October 7, 2010
A better TRAIL variant for tumor cell-specific targeting? - letterEdwin Bremer, Wijnand Helfrich
Discovery Medicine|January 20, 2007
Targeting the messengers of death: the advent of selective activation of apoptosis for cancer therapyEdwin Bremer, Wijnand Helfrich
Methods in Molecular Biology (Clifton, N.J.)|February 6, 2014
Bifunctional antibody fragment-based fusion proteins for the targeted elimination of pathogenic T-cell subsetsWijnand Helfrich, Edwin Bremer
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Direct and indirect rituximab-induced T cell depletion: comment on the article by Mélet et AlPaul Eggleton, Edwin Bremer
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
EpCAM-targeted induction of apoptosisEdwin Bremer, Wijnand Helfrich
Methods in Molecular Biology (Clifton, N.J.)|May 22, 2025
A Luminescence-Based Method for In Vitro Screening of Immunomodulatory Checkpoints and TherapeuticsJimena Álvarez Freile, Edwin Bremer
Frontiers in Oncology|December 5, 2015
Editorial: Endoplasmic Reticulum and Its Role in Tumor ImmunityPaul Eggleton, Marek Michalak, Edwin Bremer
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
Development of Bispecific Antibody Derivatives for Cancer ImmunotherapyYuan He, Wijnand Helfrich, Edwin Bremer
Frontiers in Cell and Developmental Biology|June 17, 2022
Towards Immunotherapy-Induced Normalization of the Tumor MicroenvironmentVinicio Melo, Edwin Bremer, John D Martin
Pageof 10